학술논문
68P Clinical implications of cardiotoxicity and pharmacokinetics of alectinib in patients (pts) with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC).
Document Type
Article
Author
Source
Subject
*ANAPLASTIC lymphoma kinase
*NON-small-cell lung carcinoma
*PHARMACOKINETICS
*CARDIOTOXICITY
*
*
*
Language
ISSN
0923-7534